Blasi Francesco, Bonanni Paolo, Braido Fulvio, Gabutti Giovanni, Marchetti Federico, Centanni Stefano
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Department of Internal Medicine, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Hum Vaccin Immunother. 2020;16(2):340-348. doi: 10.1080/21645515.2019.1652517. Epub 2019 Sep 6.
Despite high rates of vaccination, pertussis resurgence has been reported worldwide in recent years, including in Italy, especially in older adults.Chronic obstructive pulmonary disease (COPD) is a respiratory disease associated with progressive inflammation of the respiratory tract. Regional population studies have shown the prevalence of COPD in Italy to be approximately 15% with an age-dependent increase in proportion of COPD cases.Emerging data shows that individuals with COPD are at high risk of contracting pertussis. Furthermore, those who develop pertussis could experience exacerbation of their pre-existent COPD and further susceptibility to other infections.Immunization programs in Italy currently recommend a decennial reduced-antigen-content diphtheria-tetanus-acellular pertussis booster vaccine dose for adults. Active measures to encourage booster vaccination, especially for high-risk adults such as those with COPD, could positively impact pertussis morbidity and the associated healthcare burden.
尽管疫苗接种率很高,但近年来全球范围内都报告了百日咳疫情复发的情况,包括在意大利,尤其是在老年人中。慢性阻塞性肺疾病(COPD)是一种与呼吸道进行性炎症相关的呼吸系统疾病。区域人口研究表明,意大利COPD的患病率约为15%,且COPD病例比例随年龄增长而增加。新出现的数据表明,COPD患者感染百日咳的风险很高。此外,那些感染百日咳的人可能会使原有的COPD病情加重,并更容易感染其他疾病。意大利的免疫规划目前建议为成年人接种十年一次的低抗原含量白喉-破伤风-无细胞百日咳加强疫苗。采取积极措施鼓励加强疫苗接种,特别是针对COPD患者等高风险成年人,可能会对百日咳发病率和相关医疗负担产生积极影响。